Aurobindo Pharma | ARBP - Sales Revenues

Stock Price
1,409.85
Daily Change
-11.45 -0.81%
Monthly
8.18%
Yearly
16.55%
Q2 Forecast
1,382.70

Aurobindo Pharma reported INR86.46B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Cipla INR 75.18B 710M Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Hindustan Unilever INR 161.97B 6.12B Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 123.61B 3.42B Dec/2025